Skip to main content
Clinical Trials/NCT06690307
NCT06690307RecruitingPhase 4

The Efficacy and Safety of Oxycodone in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy

Affiliated Hospital of Nantong University1 site in 1 country64 target enrollmentStarted: December 3, 2024Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Enrollment
64
Locations
1
Primary Endpoint
NRS scores

Study Overview

Brief Summary

This study is designed to evaluate the efficacy and safety of hydrocodone in patient-controlled intravenous analgesia (PCIA) during gynecological laparoscopy, thus to explore suitable PCIA scheme to optimize postoperative pain management for patients undergoing gynecological laparoscopic surgeries.

Detailed Description

The controlled group will receive sulfentanil for PCIA, and the test group will receive hydrocodone for PCIA. NRS scores at 1, 6, 24 and 48 hours post-surgery will be recorded. The usage of rescue analgesics and adverse events will also be recorded.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • selective laparoscopic hysterectomy
  • general anesthesia
  • ASA classification I - III
  • aged 18 - 65 years

Exclusion Criteria

  • allergy to oxycodone or any other drugs will be used in the study
  • preoperative opioids medication
  • opioids abuse
  • hepatic or renal dysfunction
  • cardiovascular or pulmonary dysfunction
  • lack of full civil capacity or refuse to participate

Outcomes

Primary Outcomes

NRS scores

Time Frame: 6 hours after surgery

Postoperative pain will be evaluated on a 11point number rating scale (NRS): 0 means no pain; and 10 means worst pain imaginable.

Secondary Outcomes

  • NRS scores(30 days after surgery)
  • rescue analgesics usage(from the end of surgery to the first usage (up to 48 hours post-surgery))
  • PCIA pressing times(48 hours after surgery)
  • anal exhaust time(from the end of surgery to the first anal exhaust (up to 48 hours post-surgery))
  • adverse events(within 48 hours after surgery)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Siyuan Liu

Principal Investigator

Affiliated Hospital of Nantong University

Study Sites (1)

Loading locations...

Similar Trials